… to undergo endothelial to mesenchymal transition (EndMT), a … EndMT is a complex biological
process in which endothelial … be involved in the pathogenesis of various fibrotic disorders. …

… Both pulmonary hypertension and lung fibrosis occur in long-term survivors with … We
then focus on the role of EndoMT in the pathogenesis of these chronic lung diseases, …

… (19, 26, 27), indicating that this process is shared by many fibrotic disorders. Pericytes were
… that may regulate the endothelial-to-mesenchymal transition (EndoMT) process in systemic …

… myofibroblasts (EndoMT) during the development of organ fibrosis. In this review, we discuss
the role of EndoMT in renal fibrosis, cardiac fibrosis and pulmonary fibrosis and summarize …

… the pathogenesis of certain hereditary human vascular diseases… as an endothelial–mesenchymal
transition (EndoMT) inducer… and a novel biomarker for EndoMT in human liver fibrosis. …

… EndoMT and EndoMT-mediated pathogenesis. Most investigations have been limited to
exploring endothelial and mesenchymal … switch in cardiac fibrosis and other fibrotic diseases [31]…

… fibrosis and collagen deposition. This process is identified as endothelial-to-mesenchymal
transition (EndMT), … is pivotal to identify early pathogenetic events and new therapeutic targets …

… Furthermore, we discuss the role of EndMT in cardiovascular diseases, fibrosis, and cancer,
… for the treatment of diseases associated with/caused by EndMT. But, the discovery of …

… EndMT may prove to be effective as a therapeutic treatment. … how EndMT has been targeted
in different disease contexts. … ) was shown to block EndMT and reduce renal fibrosis [102]. …

… transition (EMT) [Citation64]. Indeed, accruing research on EndMT showed that endothelial
… contributes to the pathogenesis of several diseases such as fibrosis, pulmonary arterial …